Kalaris Therapeutics Total Risk Alpha

KLRS Stock   8.84  -0.33  -3.60%   
This technical indicator view for Total Risk Alpha organizes signals for Kalaris Therapeutics and comparable instruments. Availability can vary by instrument; Equity Screeners offers additional screening access. Kalaris Therapeutics has a market cap of 172.25 M. See Correlation Analysis for portfolio-level analysis. This suggests a position in Kalaris Therapeutics within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Our How to Buy Kalaris Stock guide explains the steps to invest in Kalaris Therapeutics stock.
Kalaris Therapeutics has current Total Risk Alpha of 1.31. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.

Total Risk Alpha

 = 

RFR + (ER[b] - ER[a])

x

STD[a] / STD[b]

 = 
1.31
ER[a] = Expected return on investing in Kalaris Therapeutics
ER[b] = Expected return on market index or selected benchmark
STD[a] =   Standard Deviation of returns on Kalaris Therapeutics
STD[b] = Standard Deviation of selected market or benchmark
RFR = Risk Free Rate of return. Typically T-Bill Rate

Kalaris Therapeutics Total Risk Alpha Peers Comparison

Kalaris Total Risk Alpha Relative To Other Indicators

Kalaris Therapeutics is rated below average in total risk alpha relative to competitors. It is currently under evaluation in maximum drawdown relative to competitors yielding 25.52 of Maximum Drawdown per Total Risk Alpha. For Kalaris Therapeutics, Maximum Drawdown stands at 25.52 times Total Risk Alpha
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Kalaris Therapeutics to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas